A randomized, double‐blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to...

por Klughammer, Barbara, Piali, Luca, Nica, Alexandra, Nagel, Sandra, Bailey, Lorna, Jochum, Christoph, Ignatenko, Stanislav, Bläuer, Angela, Danilin, Sabrina, Gulati, Pratiksha, Hayward, Joanne, Scepanovic, Petar, Zhang, Jitao David, Bhosale, Satish, Chong, Chui Fung, Christ, Andreas
Publicado 2023